Atmeksi Suspension
Product Images NDC 69528-701

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atmeksi (NDC 69528-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rosemont Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atmeksi Bottle (Atmeksi Bottle 150)

ATMEKSI methocarbamol oral suspension label showing strength 750 mg per 5 mL, in a 150 mL bottle. The label states it is prescription only, includes storage instructions at 20°C to 25°C, and manufacturer Rosemont Pharmaceuticals LLC, Greenville, SC. The label also includes lot and expiration placeholders and contact information.*

FDA Label Image

Formula (Formula)

Chemical structure of methocarbamol, the active ingredient in ATMEKSI 750 mg/5 mL oral suspension by Rosemont Pharmaceuticals LLC. The diagram illustrates the molecular arrangement of methocarbamol, showing aromatic rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.